Gapping up
In reaction to strong earnings/guidance: EEI +14.6%, BOBE +4.7%, ITI +1.1%
M&A news: QIHU +9.1% (receives non-binding proposal to be acquired for $77/share by group including its Chairman and CEO), TMUS +2.3% (Deutsche Telecom (DTEGY) is working with Comcast (CMCSA) on T Mobile sale, according to Manager-Magazine)
Select China related names showing strength: SHI +5.3%, SFUN +4.6%, CO +4.4%, DANG +2.5%, KNDI +2.4%
Select oil/gas related names showing strength: SD +1.8%, RIG +1.3%, CHK +0.9%, STO +0.8%, COP +0.6%, VLO +0.5%
Other news: SGYP +53.4% (announces positive results in its first Phase 3 trial of Plecanatide to treat chronic idiopathic constipation), KYTH +22.4% (to be acquired by Allergan (AGN) for $75 per share), TRCH +14.3% (signs LOI for portion of Hunton assets), FREE +9.9% (cont strength), MANU +9.2% (Ron Baron spoke favorably on CNBC; continues to like),MDXG +5% (CEO interview on CNBC who discussed that the co's amniotic membrane tissue may help wounds heal faster), ARWR +3.1% (receives regulatory clearance in Germany to begin additional phase 2b studies of HBV candidate ARC-520), RLH +2.8% (HNA Group acquired ~3 mln shares of RLH's common stock), directly from Columbia Pacific), JAKK+2.3% (still checking), ANTH +2.1% (announced that it has met the enrollment target of its CHABLIS-SC1 Phase 3 clinical trial evaluating blisibimod for the treatment of lupus. Final data from the trial is expected in the second half of 2016), ERN +2.1% (issues response to allegations raised in an article authored by Cannell Capital), SDRL +2% (sells ultra-deepwater drillship the West Polaris to Seadrill Partners), DOW +1.6% (still checking), MBLY +1.6% (Ron Baron spoke favorably on CNBC; continues to like), CELG +1.3% (announces additional $4 billion share repurchase authorization), TASR +1% (announces new orders for its smart weapons), FFIC +0.9% (announced authorization of 1 mln share stock repurchase program)
Analyst comments: HIMX +4.1% (target raised to $11 from $9 at Northland Capital), MXWL +3.5% (upgraded to Outperform from Market Perform at Northland ), WLL +2.3% (upgraded to Buy from Neutral at Citigroup), STR +1.1% (upgraded to Buy from Hold at Jefferies), CRR +1.1% (upgraded to Sector Perform from Underperform at Iberia), RSTI +1% (initiated with a Buy at The Benchmark Company ), ADPT +0.9% (Adeptus Health target raised to $102 from $69 at Piper Jaffray), BTI +0.7% (upgraded to Neutral from Sell at Goldman), FB +0.7% (target raised to $108 at Brean Capital
)
In reaction to strong earnings/guidance: EEI +14.6%, BOBE +4.7%, ITI +1.1%
M&A news: QIHU +9.1% (receives non-binding proposal to be acquired for $77/share by group including its Chairman and CEO), TMUS +2.3% (Deutsche Telecom (DTEGY) is working with Comcast (CMCSA) on T Mobile sale, according to Manager-Magazine)
Select China related names showing strength: SHI +5.3%, SFUN +4.6%, CO +4.4%, DANG +2.5%, KNDI +2.4%
Select oil/gas related names showing strength: SD +1.8%, RIG +1.3%, CHK +0.9%, STO +0.8%, COP +0.6%, VLO +0.5%
Other news: SGYP +53.4% (announces positive results in its first Phase 3 trial of Plecanatide to treat chronic idiopathic constipation), KYTH +22.4% (to be acquired by Allergan (AGN) for $75 per share), TRCH +14.3% (signs LOI for portion of Hunton assets), FREE +9.9% (cont strength), MANU +9.2% (Ron Baron spoke favorably on CNBC; continues to like),MDXG +5% (CEO interview on CNBC who discussed that the co's amniotic membrane tissue may help wounds heal faster), ARWR +3.1% (receives regulatory clearance in Germany to begin additional phase 2b studies of HBV candidate ARC-520), RLH +2.8% (HNA Group acquired ~3 mln shares of RLH's common stock), directly from Columbia Pacific), JAKK+2.3% (still checking), ANTH +2.1% (announced that it has met the enrollment target of its CHABLIS-SC1 Phase 3 clinical trial evaluating blisibimod for the treatment of lupus. Final data from the trial is expected in the second half of 2016), ERN +2.1% (issues response to allegations raised in an article authored by Cannell Capital), SDRL +2% (sells ultra-deepwater drillship the West Polaris to Seadrill Partners), DOW +1.6% (still checking), MBLY +1.6% (Ron Baron spoke favorably on CNBC; continues to like), CELG +1.3% (announces additional $4 billion share repurchase authorization), TASR +1% (announces new orders for its smart weapons), FFIC +0.9% (announced authorization of 1 mln share stock repurchase program)
Analyst comments: HIMX +4.1% (target raised to $11 from $9 at Northland Capital), MXWL +3.5% (upgraded to Outperform from Market Perform at Northland ), WLL +2.3% (upgraded to Buy from Neutral at Citigroup), STR +1.1% (upgraded to Buy from Hold at Jefferies), CRR +1.1% (upgraded to Sector Perform from Underperform at Iberia), RSTI +1% (initiated with a Buy at The Benchmark Company ), ADPT +0.9% (Adeptus Health target raised to $102 from $69 at Piper Jaffray), BTI +0.7% (upgraded to Neutral from Sell at Goldman), FB +0.7% (target raised to $108 at Brean Capital
)